My Account

Tuesday, December 3, 2024

Canada’s Politics and Government News Source Since 1989

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.

News
BY JESSE CNOCKAERT
April 1, 2024

News | BY JESSE CNOCKAERT | April 1, 2024

More News

Liberal to independent: Jane Cordy looks back on 24 years in the Senate

NewsBY LAURA RYCKEWAERT

As Trump threatens 25 per cent tariffs, revived Canada-U.S. Cabinet Committee meets weekly

NewsBY ABBAS RANA

Some Liberal MPs upset with Trudeau for not consulting caucus or cabinet before announcing two-month GST holiday and $250 cheques

NewsBY ABBAS RANA

House Finance Committee receives more than 800 briefs ahead of 2025 budget

NewsBY STEPHEN JEFFERY

Climate change, housing needs of Northern Canada require tailored funding model based on more than population, say Idlout and Simpson

NewsBY JESSE CNOCKAERT

Canadians see improvements to Indigenous, gender rights over time, but cool on welcoming immigrants, asylum seekers: survey

NewsBY STEPHEN JEFFERY

Approximately two-thirds of respondents were hopeful about the future of human rights within Canada in 2024, but only 37 per cent shared that sentiment about the global situation.

Canadians see improvements to Indigenous, gender rights over time, but cool on welcoming immigrants, asylum seekers: survey

NewsBY STEPHEN JEFFERY

Approximately two-thirds of respondents were hopeful about the future of human rights within Canada in 2024, but only 37 per cent shared that sentiment about the global situation.

Most-lobbied Grit MPs hear push for health accountability measures, most-lobbied Tory MPs hear push for environment, trade issues

House gridlock remains as Canada seeks to quickly respond to Trump tariff threats

As Trump’s tariff threats fly at the ‘whim of a tweet,’ Canada needs united front, says federalism expert

The NDP-backed pharmacare plan is a corporate handout as written

OpinionBY STEVE MORGAN, MATTHEW HERDER, NAV PERSAUD

Pharmacare bill and Liberal messaging at odds, confusing stakeholders on vision for ‘single-payer’ system

NewsBY TESSIE SANCI

Patients know about pharmacare: let’s listen to them on Bill C-64

OpinionBY JOHN ADAMS, LINDA WILHELM

Next step in universal drug coverage should prioritize ‘essential medicines,’ says pharmacare expert

NewsBY JESSE CNOCKAERT

Patient involvement in pharmacare is critical to its success

OpinionBY LOUISE BINDER AND FILOMENA SERVIDIO-ITALIANO

The NDP-backed pharmacare plan is a corporate handout as written

OpinionBY STEVE MORGAN, MATTHEW HERDER, NAV PERSAUD

The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.

The NDP-backed pharmacare plan is a corporate handout as written

OpinionBY STEVE MORGAN, MATTHEW HERDER, NAV PERSAUD

The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.

Pharmacare bill and Liberal messaging at odds, confusing stakeholders on vision for ‘single-payer’ system

NewsBY TESSIE SANCI

The language in the pharmacare bill is ‘fatally flawed,’ according to pharmacare expert Dr. Steve Morgan.

Pharmacare bill and Liberal messaging at odds, confusing stakeholders on vision for ‘single-payer’ system

NewsBY TESSIE SANCI

The language in the pharmacare bill is ‘fatally flawed,’ according to pharmacare expert Dr. Steve Morgan.

Patients know about pharmacare: let’s listen to them on Bill C-64

OpinionBY JOHN ADAMS, LINDA WILHELM

Patient groups’ involvement should be built into the program, not just a one-time pre-consultation.

Patients know about pharmacare: let’s listen to them on Bill C-64

OpinionBY JOHN ADAMS, LINDA WILHELM

Patient groups’ involvement should be built into the program, not just a one-time pre-consultation.

Next step in universal drug coverage should prioritize ‘essential medicines,’ says pharmacare expert

NewsBY JESSE CNOCKAERT

Focusing on a list of the most commonly prescribed clinically-important drugs could save billions of dollars, both directly in terms of drug budget, and indirectly in terms of improvements in health care, says Steve Morgan, a professor of health policy at the University of British Columbia.

Next step in universal drug coverage should prioritize ‘essential medicines,’ says pharmacare expert

NewsBY JESSE CNOCKAERT

Focusing on a list of the most commonly prescribed clinically-important drugs could save billions of dollars, both directly in terms of drug budget, and indirectly in terms of improvements in health care, says Steve Morgan, a professor of health policy at the University of British Columbia.

Patient involvement in pharmacare is critical to its success

OpinionBY LOUISE BINDER AND FILOMENA SERVIDIO-ITALIANO

Pharmacare is the most innovative and important health policy legislation in decades. To get it right, the federal government must directly engage with patients. Their expertise is crucial to pharmacare’s success.

Patient involvement in pharmacare is critical to its success

OpinionBY LOUISE BINDER AND FILOMENA SERVIDIO-ITALIANO

Pharmacare is the most innovative and important health policy legislation in decades. To get it right, the federal government must directly engage with patients. Their expertise is crucial to pharmacare’s success.

First phase of pharmacare must not ‘create new gaps’ in existing coverage, say lobbyists

Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.

Become a Political Insider

1

2

3

4

5

6

7

8